Literature DB >> 26536867

Real-time safety surveillance of seasonal influenza vaccines in children, Australia, 2015.

Alexis Pillsbury1, Patrick Cashman, Alan Leeb, Annette Regan, Darren Westphal, Tom Snelling, Christopher Blyth, Nigel Crawford, Nicholas Wood, Kristine Macartney.   

Abstract

Increased febrile reactions in Australian children from one influenza vaccine brand in 2010 diminished confidence in influenza immunisation, highlighting the need for improved vaccine safety surveillance. AusVaxSafety, a national vaccine safety surveillance system collected adverse events in young children for 2015 influenza vaccine brands in real time through parent/carer reports via SMS/email. Weekly cumulative data on 3,340 children demonstrated low rates of fever (4.4%) and medical attendance (1.1%). Fever was more frequent with concomitant vaccination.

Entities:  

Keywords:  Australia; Influenza; active surveillance; vaccine safety

Mesh:

Substances:

Year:  2015        PMID: 26536867     DOI: 10.2807/1560-7917.ES.2015.20.43.30050

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  14 in total

1.  Influenza hospitalizations in Australian children.

Authors:  J Li-Kim-Moy; J K Yin; C C Blyth; A Kesson; R Booy; A C Cheng; K Macartney
Journal:  Epidemiol Infect       Date:  2017-02-06       Impact factor: 4.434

2.  Allergic adverse events following 2015 seasonal influenza vaccine, Victoria, Australia.

Authors:  Hazel J Clothier; Nigel Crawford; Melissa A Russell; Jim P Buttery
Journal:  Euro Surveill       Date:  2017-05-18

Review 3.  Participant-centred active surveillance of adverse events following immunisation: a narrative review.

Authors:  Patrick Cashman; Kristine Macartney; Gulam Khandaker; Catherine King; Michael Gold; David N Durrheim
Journal:  Int Health       Date:  2017-05-01       Impact factor: 2.473

4.  2017/18 and 2018/19 seasonal influenza vaccine safety surveillance, Canadian National Vaccine Safety (CANVAS) Network.

Authors:  Julie A Bettinger; Gaston De Serres; Louis Valiquette; Otto G Vanderkooi; James D Kellner; Brenda L Coleman; Karina A Top; Jennifer E Isenor; Anne E McCarthy
Journal:  Euro Surveill       Date:  2020-06

Review 5.  The use of technology to promote vaccination: A social ecological model based framework.

Authors:  Chelsea A Kolff; Vanessa P Scott; Melissa S Stockwell
Journal:  Hum Vaccin Immunother       Date:  2018-07-03       Impact factor: 3.452

6.  Use of routinely collected electronic healthcare data for postlicensure vaccine safety signal detection: a systematic review.

Authors:  Yonatan Moges Mesfin; Allen Cheng; Jock Lawrie; Jim Buttery
Journal:  BMJ Glob Health       Date:  2019-07-08

7.  Participant-Centered Online Active Surveillance for Adverse Events Following Vaccination in a Large Clinical Trial: Feasibility and Usability Study.

Authors:  Sally-Anne Munnoch; Patrick Cashman; Roseanne Peel; John Attia; Alexis Hure; David N Durrheim
Journal:  J Med Internet Res       Date:  2019-10-23       Impact factor: 5.428

8.  Timeliness of signal detection for adverse events following influenza vaccination in young children: a simulation case study.

Authors:  Peter Jacoby; Catherine Glover; Chloe Damon; Parveen Fathima; Alexis Pillsbury; David Durrheim; Michael S Gold; Alan Leeb; Tom Snelling
Journal:  BMJ Open       Date:  2020-03-01       Impact factor: 2.692

9.  Post-Marketing Active Surveillance of Adverse Reactions Following Influenza Cell-Based Quadrivalent Vaccine: An Italian Prospective Observational Study.

Authors:  Pasquale Stefanizzi; Sara De Nitto; Giuseppe Spinelli; Sabrina Lattanzio; Paolo Stella; Domenica Ancona; Maria Dell'Aera; Margherita Padovano; Savino Soldano; Silvio Tafuri; Francesco Paolo Bianchi
Journal:  Vaccines (Basel)       Date:  2021-05-04

10.  Active surveillance of 2017 seasonal influenza vaccine safety: an observational cohort study of individuals aged 6 months and older in Australia.

Authors:  Alexis J Pillsbury; Catherine Glover; Peter Jacoby; Helen E Quinn; Parveen Fathima; Patrick Cashman; Alan Leeb; Christopher C Blyth; Michael S Gold; Thomas Snelling; Kristine K Macartney
Journal:  BMJ Open       Date:  2018-10-18       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.